Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma.
Dequen, P Jansen, J van Baardewijk, M Ouwens, M Kotapati, S
Dequen, P
Jansen, J
van Baardewijk, M
Ouwens, M
Kotapati, S
Citations
Altmetric:
Abstract
To compare the overall survival (OS) of patients treated with 3 mg/kg ipilimumab versus alternative systemic therapies in pretreated unresectable stage III or IV melanoma patients.
Affiliation
Description
Date
2012
Publisher
Collections
Keywords
Type
Article
Citation
Systematic review and network meta-analysis of overall survival comparing 3 mg/kg Ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma. 2012, 17 (11):1376-85 Oncologist